Shopping Cart
  • Remove All
  • TargetMol
    Your shopping cart is currently empty

Ossirene

🥰Excellent
Catalog No. T6761Cas No. 106566-58-9
Alias AS101

Ossirene (AS101), a potent in vitro and in vivo immunomodulator, is a novel inhibitor of IL-1beta converting enzyme.

Ossirene

Ossirene

🥰Excellent
Catalog No. T6761Alias AS101Cas No. 106566-58-9
Ossirene (AS101), a potent in vitro and in vivo immunomodulator, is a novel inhibitor of IL-1beta converting enzyme.
Pack SizePriceAvailabilityQuantity
1 mg32 €In Stock
5 mg75 €In Stock
10 mg115 €In Stock
25 mg182 €In Stock
50 mg278 €In Stock
100 mg418 €In Stock
200 mg616 €In Stock
Bulk & Custom
Add to Cart
Questions
View More

Related Compound Libraries of "Ossirene"

Select Batch
Contact us for more batch information
Resource Download
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.

Product Introduction

Bioactivity
Description
Ossirene (AS101), a potent in vitro and in vivo immunomodulator, is a novel inhibitor of IL-1beta converting enzyme.
In vitro
Treatment of caspase-1 (interleukin-1 [IL-1] converting enzyme [ICE]) with Ossirene inhibits its enzymatic activity in a dose-dependent manner. Moreover, Ossirene treatment causes a significant reduction in the active form of IL-18 and IL-1 in peripheral blood mononuclear cells (PBMC) and in human HaCat keratinocytes. The inhibitory effect of Ossirene does not involve nitric oxide (NO) or interferon- (IFN- ), two possible regulators of IL-18 production, and does not occur at the mRNA level. It may exert effects through a posttranscriptional mechanism[1]. Ossirene induced SIRT1 expression in a dose dependent manner in three different cell lines, HEK293, HL-60 and Rin-5f. Incubation of HEK293 and HL-60 cell lines with Ossirene (0.1-2.5μg/ml) resulted in a dose dependent reduction in PPARγ protein expression relative to the control cells, and the reduction of PPARγ expression is in parallel to increased SIRT1 expression[2].
In vivo
Ossirene downregulates IL-18 and IL-1 serum levels in a mouse model of lipopolysaccharide (LPS)-induced sepsis, resulting in increased survival. It has also been shown to be protective against lethal and sublethal effects of irradiation and chemotherapy. In a model of cecal ligation and puncture (CLP)-induced sepsis in mice, Ossirene also exerted beneficial effects[1]. Ossirene treated rats showed a large increase in SIRT1 protein levels in the liver and kidney extracts of rats treated with Ossirene. Ossirene prevents development of insulin resistance in vivo. Ossirene affects SIRT1 related metabolic pathways by changing the insulin levels. Ossirene treatment prevents hyperglycemia associated with T2D(type 2 diabetes) and some of the symptoms of the disease in the HFD(high fat diet)+STZ(Streptozotocin) rat model[2].
Cell Research
In vitro, PBMCs were first treated with various concentrations of AS101, and after 1 h SAC (10-3 v/v) was added. After 24 h, supernatants were collected and evaluated for cytokine content. (Only for Reference)
AliasAS101
Chemical Properties
Molecular Weight312.05
FormulaC2H4Cl3O2Te·H4N
Cas No.106566-58-9
Smiles[NH4+].Cl[Te-]1(Cl)(Cl)OCCO1
Relative Density.1.097g/cm3
Storage & Solubility Information
StoragePowder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice.
Solubility Information
DMSO: 5.63 mg/mL (18.03 mM), Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM3.2046 mL16.0231 mL32.0461 mL160.2307 mL
5 mM0.6409 mL3.2046 mL6.4092 mL32.0461 mL
10 mM0.3205 mL1.6023 mL3.2046 mL16.0231 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the mother liquor preparation method and in vivo formula preparation method:
TargetMol | Animal experimentsFor example, your dosage is 10 mg/kg Each animal weighs 20 g, and the dosage volume is 100 μL . TargetMol | Animal experiments A total of 10 animals were administered, and the formula you used is 5% TargetMol | reagent DMSO+30% PEG300+5% Tween 80+60% ddH2O. So your working solution concentration is 2 mg/mL。
Mother liquor preparation method: 2 mg of drug dissolved in 50 μL DMSOTargetMol | reagent (mother liquor concentration of 40 mg/mL), if you need to configure a concentration that exceeds the solubility of the product, please contact us first.
Preparation method for in vivo formula: Take 50 μL DMSOTargetMol | reagent main solution, add 300 μLPEG300TargetMol | reagent mix well and clarify, then add 50 more μL Tween 80, mix well and clarify, then add 600 more μLddH2OTargetMol | reagent mix well and clarify
For Reference Only. Please develop an appropriate dissolution method based on your laboratory animals and route of administration.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
%Tween 80
%ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Ossirene | purchase Ossirene | Ossirene cost | order Ossirene | Ossirene chemical structure | Ossirene in vivo | Ossirene in vitro | Ossirene formula | Ossirene molecular weight